Phase I PET imaging trial of SYN 120 in healthy volunteers: a pharmacokinetic trial.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2012
At a glance
- Drugs Landipirdine (Primary)
- Indications Cognition disorders
- Focus Pharmacokinetics
- 01 Mar 2012 Status changed from recruiting to completed, as reported in a Biotie media release.
- 24 Feb 2012 Planned End Date changed from 1 Mar 2012 to 1 Jun 2012, according to a BioTie Therapies Corp media release.
- 25 Jul 2011 Status changed from planning to recruiting according to a Biotie Therapies media release.